SRPT

Quote

Short

News

Articles

Message Board

Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call Transcript

November 04, 2025 05:36:24 am

Source: SeekingAlpha

2025-11-04 05:36:24 ET

Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST...

Read the full article on Seeking Alpha

For further details see:

Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call Transcript

Sarepta Therapeutics Inc.

NASDAQ: SRPT

SRPT Trading

1.05% G/L:

$17.35 Last:

894,838 Volume:

$16.93 Open:

mwn-alerts Ad 300

SRPT Latest News

March 21, 2026 04:20:00 pm

2 Beaten-Down Stocks That Still Aren't Worth Buying

March 19, 2026 08:30:00 am

Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®

March 16, 2026 08:33:00 am

Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne

March 12, 2026 08:03:22 pm

SRPT Price Target Alert: $31.00. Issued by Mizuho Securities

SRPT Stock Data

Market Cap $1,921,797,010

Float 96,823,361

Insiders Ownership N/A

Institutions 132

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.sarepta.com

Country US

City Cambridge

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App